Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
heme arginate |
| gptkbp:activeIngredient |
gptkb:hemin
|
| gptkbp:ATCCode |
B06AB
|
| gptkbp:CASNumber |
16009-13-5
|
| gptkbp:color |
dark brown
|
| gptkbp:contraindication |
known hypersensitivity to hemin
|
| gptkbp:FDAApproved |
approved
|
| gptkbp:form |
lyophilized powder for solution
|
| https://www.w3.org/2000/01/rdf-schema#label |
Panhematin
|
| gptkbp:indication |
porphyria attack
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Recordati_Rare_Diseases
|
| gptkbp:mechanismOfAction |
inhibits ALA synthase
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
phlebitis
iron overload coagulopathy |
| gptkbp:UNII |
N3R1E4A5G2
|
| gptkbp:usedFor |
gptkb:acute_intermittent_porphyria
|
| gptkbp:bfsParent |
gptkb:hemin
|
| gptkbp:bfsLayer |
8
|